Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet AMD”

Showing 20 of 0 results

Not applicableStudy completedNCT05111743
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,261
Not applicableUnknownNCT05757674
What this trial is testing

Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Ioannina 130
Testing effectiveness (Phase 2)Study completedNCT00239928
What this trial is testing

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 61
Testing effectiveness (Phase 2)Study completedNCT03861234
What this trial is testing

Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 43
Not applicableStudy completedNCT05110209
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 331,541
Testing effectiveness (Phase 2)UnknownNCT02098720
What this trial is testing

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Very Low Vision Secondary to Wet Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 30
Not applicableStudy completedNCT02762188
What this trial is testing

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Who this might be right for
Age-Related Macular Degeneration
Brugmann University Hospital 501
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Not applicableStudy completedNCT07744984
What this trial is testing

The Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to Faricimab

Who this might be right for
Age-Related Macular Degeneration (AMD)Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Rabin Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT01249937
What this trial is testing

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
University Health Network, Toronto 30
Early research (Phase 1)Study completedNCT00503022
What this trial is testing

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798375
What this trial is testing

Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration(nAMD)
Everest Medicines (China) Co.,Ltd. 244
Large-scale testing (Phase 3)Looking for participantsNCT07317934
What this trial is testing

Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Innostellar Biotherapeutics Co.,Ltd 388
Testing effectiveness (Phase 2)Study completedNCT00138632
What this trial is testing

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis 50
Not applicableStudy completedNCT00804934
What this trial is testing

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

Who this might be right for
Wet AMD
Retina Institute of Hawaii 100
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Early research (Phase 1)Study completedNCT02061865
What this trial is testing

Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

Who this might be right for
Neovascular Wet Age-related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 12
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01414153
What this trial is testing

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Lpath, Inc. 158
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation